Skip to content

Efficacy and Safety of Jin's 3 needle Technique for Chronic Fatigue Syndrome: a Multicentre, Single-Blind, Randomized Controlled Trial

Efficacy and Safety of Jin's 3 needle Technique for Chronic Fatigue Syndrome: a Multicentre, Single-Blind, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011009
Enrollment
Unknown
Registered
2017-03-29
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Interventions

the test group:Acupuncture on the Jin's 3-needle group combined with routine acupuncture treatment.
the controlled group:Only routine acupuncture treatment.

Sponsors

The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria of CFS.( published in 1994, by Centers for Disease Control); (2) Patients aged between 20 to 55 years; (3) Patients volunteered to participate in the study and signed informed consent; (4) Patients have not accepted any related therapy such as Pharmacotherapy and psychotherapy in one month; (5) Education with junior high school or above, have the ability to understand the scale.

Exclusion criteria

Exclusion criteria: (1) Pregnancy and lactating women, and women who have fertility intentionin the coming 3 months; (2) Patients who combined with contagious disease, mental illness, cardiovascular diseases, or primary diseases of liver, kidney, hematopoietic and endocrine system; (3) Patients had hemorrhagic disease or bleeding tendency; (4) Patients had trauma, fever or allergic history in recent 2 weeks; (5) Patients fainting during acupuncture or at the sight of blood; (6) Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Fatigue Scale-14 score;Fatigue Assessment Scale (FAI) score;Depression Status Inventory(DSI)score;Self-Rating Anxiety Scale(SAS) score;

Secondary

MeasureTime frame
Adrenocorticotropic Hormone(ACTH);Plasma Cortisol (CORT);Serum levels of IL-2;Serum levels of IFN-?;

Countries

China

Contacts

Public ContactXinghua Chen

The First Affiliated Hospital, Guangzhou University of Chinese Medicine

xinghuac@outlook.com+86 13631382393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 3, 2026